SPACA6 and breast cancer: Finally, H&E staining revealed alterations in tumor tissue structure following SPACA6P-AS silencing (Fig. 11E), and a reduction in Ki-67 labeling further verified the proliferative role of SPACA6P-AS in BC cells (Fig. 11F).